Surgalign Holdings
-
Spine
Surgalign Launches Portfolio of Fortilink® with TiPlus™ Technology Products, Expanding its Addressable Market for Interbody Fusion Procedures
Broadens Fortilink interbody product line to now include both titanium and 3D-printed polymer options. DEERFIELD, Ill., Sept. 26, 2022 (GLOBE NEWSWIRE)…
Read More » -
Spine
Surgalign Announces Third Clinical Site in the Commercialization of its HOLO Portal™ Surgical Guidance System
Dr. Jaideep Chunduri of Beacon Orthopedics & Sports Medicine in Cincinnati, OH utilizes HOLO Portal, the world’s first artificial intelligence…
Read More » -
Spine
Surgalign to Exhibit at the Society for Minimally Invasive Spine Surgery (“SMISS”) Annual Forum and the North American Spine Society (“NASS”) 2022 Annual Meeting
Company to showcase its HOLO Portal™ surgical guidance system for the first time at an industry event, with live, hands-on…
Read More » -
Regulatory
Surgalign Announces FDA 510(k) Clearance of the Cortera™ Spinal Fixation System – The Company’s New Flagship Posterior Fixation Platform
DEERFIELD, Ill., Aug. 24, 2022 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on…
Read More » -
Regulatory
Surgalign Announces Global Settlement Agreement with Resolve Surgical Technologies and RTI Surgical, Inc.
Parties enter into new sole-source supply relationship, extended for two years DEERFIELD, Ill., Aug. 10, 2022 (GLOBE NEWSWIRE) — Surgalign…
Read More » -
Financial
Surgalign Holdings, Inc. Announces Second Quarter 2022 Results and Reiterates Full Year 2022 Revenue Guidance Range
DEERFIELD, Ill., Aug. 09, 2022 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on…
Read More » -
Financial
Surgalign Reaches Settlement with the Securities and Exchange Commission on Matters Related to Prior Management Between 2015-2019
DEERFIELD, Ill., Aug. 03, 2022 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc., (NASDAQ: SRGA) reached a settlement with the U.S. Securities…
Read More » -
Spine
Surgalign Announces the Commercial Relaunch of its Next Generation CervAlign Anterior Cervical Plate System Optimized for Discectomy and Fusion Procedures
DEERFIELD, Ill., July 20, 2022 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on…
Read More » -
Spine
Surgalign Announces Partnership with PRIA Healthcare to Improve Patient Healthcare Coverage
Program to aid in patient access to Surgalign’s Coflex® Interlaminar Stabilization® and SImmetry® SI Joint Fusion Systems DEERFIELD, Ill., July 14, 2022…
Read More » -
Spine
Surgalign™ Announces Clinical Site Expansion in the Commercialization of its HOLO Portal™ Surgical Guidance System in Ohio
This marks the second medical facility to clinically use HOLO Portal, the world’s first artificial intelligence (AI)-driven, augmented reality (AR)…
Read More » -
Financial
Surgalign Holdings, Inc. Announces First Quarter 2022 Results and Raises Full Year 2022 Revenue Guidance Range
DEERFIELD, Ill., May 10, 2022 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on…
Read More » -
Spine
Surgalign™ Announces the First Successful Surgical Procedure Utilizing its HOLO Portal™ Surgical Guidance System
Indiana Spine Hospital is the first to utilize the HOLO Portal system, the world’s first artificial intelligence (AI) and augmented…
Read More » -
Spine
New EVoluSIon Study Data Demonstrates Strong Support for the SImmetry® Sacroiliac Joint Fusion System
Study published in the IJSS shows Surgalign product to be a reliable solution for SIJ dysfunction DEERFIELD, Ill., March 24,…
Read More » -
Financial
Surgalign Holdings, Inc. Announces Fourth Quarter and Full Year 2021 Results
DEERFIELD, Ill., March 15, 2022 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on…
Read More » -
Financial
Surgalign Receives FDA Clearance for HOLO Portal™ System, the World’s First AI-driven AR Guidance System for Spine Surgery and Reports Preliminary Fourth Quarter and Full Year 2021 Results
Clearance is for use in the lumbar portion of the $5 billion instrumented fusion market* DEERFIELD, Ill., Jan. 18, 2022…
Read More »